IPO registrations (S-1, F-1) · Registrants
PRA Health Sciences, Inc.
- SEC CIK
- 1613859 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2014-09-08, last 2014-11-07; 1 initial registration, 5 amendments
- Outcome
- Final prospectus filed 2014-11-14; declared effective 2014-11-12
- Industry (SIC)
- Services-Commercial Physical & Biological Research 8731
- Incorporated in
- DE
- Business address
- 4130 PARKLAKE AVENUE, SUITE 400, Raleigh, NC 27612
- EIN
- 46-3640387
- EDGAR entity type
- operating
- Insiders and CEO pay
- PRA Health Sciences, Inc. on the corporate pages
Offering terms
- Proposed price range
- $20.00–$23.00 per share (S-1/A filed 2014-11-07)
- Final price
- $18.00 per share, below the range (424B4 filed 2014-11-14, an initial public offering)
- Shares sold
- 16,976,744
- Gross proceeds
- $305,581,392 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol PRAH
- Lead underwriters
- Jefferies; Citigroup; UBS; Credit Suisse; Wells Fargo
- Syndicate
- Baird; William Blair
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- SEC filer: PRA Health Sciences, Inc. EXACT (CIK (EXACT))
Filings 8
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2014-09-08 | S-1 | S-1 (registration) | PRA Health Sciences, Inc. | 0001047469-14-007456 ↗ |
| 2014-09-17 | S-1/A | S-1/A (amendment) | PRA Health Sciences, Inc. | 0001047469-14-007709 ↗ |
| 2014-10-08 | S-1/A | S-1/A (amendment) | PRA Health Sciences, Inc. | 0001047469-14-008186 ↗ |
| 2014-10-29 | S-1/A | S-1/A (amendment) | PRA Health Sciences, Inc. | 0001047469-14-008666 ↗ |
| 2014-11-03 | S-1/A | S-1/A (amendment) | PRA Health Sciences, Inc. | 0001047469-14-008739 ↗ |
| 2014-11-07 | S-1/A | S-1/A (amendment) | PRA Health Sciences, Inc. | 0001047469-14-008967 ↗ |
| 2014-11-12 | EFFECT | EFFECT (declared effective) | PRA Health Sciences, Inc. | 9999999995-14-003328 ↗ |
| 2014-11-14 | 424B4 | 424B4 (final prospectus) | PRA Health Sciences, Inc. | 0001047469-14-009203 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2014-11-07 | S-1/A | registration statement | $20.00–$23.00 | 18,604,651 | - | Nasdaq PRAH | 7 | primary document; range, shares headline, cover names 7 | document ↗ | |
| 2014-11-14 | 424B4 | final prospectus | $18.00 | 16,976,744 | $305,581,392 | Nasdaq PRAH | 7 | primary document; price sentence, shares headline, proceeds table, cover names 7 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| BADDOUR LINDA | Officer | Executive VP & CFO | 12 | 2014–2018 | |
| Barber Jeffrey T | Director | 9 | 2014–2021 | ||
| Dockhorn David W | Officer | EVP and CCO; Executive Vice President & CCO; Executive VP & CCO | 6 | 2014–2018 | |
| KKR Associates North America XI L.P. | TenPercentOwner | 6 | 2014–2018 | ||
| KKR & Co. Inc. | TenPercentOwner | 7 | 2014–2019 | ||
| KKR Fund Holdings GP Ltd | TenPercentOwner | 7 | 2014–2019 | ||
| KKR Fund Holdings L.P. | TenPercentOwner | 7 | 2014–2019 | ||
| KKR Group Holdings L.P. | TenPercentOwner | 6 | 2014–2018 | ||
| KKR Group Ltd | TenPercentOwner | 6 | 2014–2018 | ||
| KKR Management LLC | TenPercentOwner | 7 | 2014–2019 | ||
| KKR North America Fund XI L.P. | TenPercentOwner | 7 | 2014–2019 | ||
| KKR North America XI Ltd | TenPercentOwner | 7 | 2014–2019 | ||
| KKR PRA Investors GP LLC | TenPercentOwner | 7 | 2014–2019 | ||
| KKR PRA Investors L.P. | TenPercentOwner | 7 | 2014–2019 | ||
| KRAVIS HENRY R | TenPercentOwner | 7 | 2014–2019 | ||
| Lin Max | Director | 1 | 2014 | ||
| MOMTAZEE JAMES C | Director | 5 | 2014–2021 | ||
| ROBERTS GEORGE R | TenPercentOwner | 7 | 2014–2019 | ||
| Satvat Ali J | Director | 1 | 2014 | ||
| SHANNON COLIN | Director,Officer | President and CEO; President & CEO | 19 | 2014–2021 | |
| Young Matthew P. | Director | 10 | 2015–2021 | ||
| KKR PRA Investors GP II LLC | TenPercentOwner | 7 | 2015–2019 | ||
| Grais Linda | Director | 9 | 2015–2021 | ||
| Dickinson Alexander George | Director | 7 | 2017–2021 | ||
| Bonello Michael J. | Officer | EVP & CFO; Exec VP & CFO | 12 | 2018–2021 | |
| KKR Group Holdings Corp. | TenPercentOwner | 3 | 2018–2019 | ||
| Gaenzle Christopher L | Officer | EVP, CAO & General Counsel; EVP, Chf Admin Ofcr & Gen Coun; EVP, Chief Admin Officer & GC | 8 | 2020–2021 | |
| Stettin Glen D. | Director | 4 | 2020–2021 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Contractor | PRA HEALTH SCIENCES | NC | Nonprofit contractors (Form 990) | name and state |
| Patent assignee | PRA Health Sciences, Inc. | NC | Patents (USPTO) | name and state |
| SEC filer | PRA Health Sciences, Inc. | SEC filers (EDGAR) | CIK (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Services-Commercial Physical & Biological Research, NC first:
- Icoria, Inc. NC
- INVERESK RESEARCH GROUP INC NC
- PRA International, LLC NC
- IQVIA HOLDINGS INC. NC
- Icagen, Inc. NC
- Syneos Health, Inc. NC
- PPD, Inc. NC
- Science 37 Holdings, Inc. NC
- WEED, INC. AZ
- GLYCOTEX, INC. C3
In other datasets, the same topic (Medical research) in NC:
- Form D issuer: 22nd Century Group, Inc. (Form D private offerings)
- Nonprofit: 3000 MILES FOR AUTISM (Nonprofits (IRS Form 990))
Interests: Services-Commercial Physical & Biological Research · Medical research